ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,867Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 197

$1.83M Total Retail Price of All Prescriptions

Rank: 1 out of 197

874 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 874 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

2% of this provider’s 874 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 5,632 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$115 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
VENLAFAXINE HCL ER 1,126 542 10 1 14
DIVALPROEX SODIUM ER 1,118 319 10 2 6
QUETIAPINE FUMARATE 998 341 3 3
TRAZODONE HCL 850 312 4 1
RISPERIDONE 627 152 5 2
LAMOTRIGINE 607 158 6 16
OLANZAPINE 539 201 7 13
SEROQUEL 484 152 8 17
FLUOXETINE HCL 470 141 9 12
DONEPEZIL HCL 431 368 10 27
SERTRALINE HCL 427 162 11 7
ZOLPIDEM TARTRATE 401 97 12 11
MIRTAZAPINE 349 195 13 9
CYMBALTA 341 117 14 5
NAMENDA 325 301 15 21
ABILIFY 322 42 16 10
CITALOPRAM HBR 322 106 16 8
ESCITALOPRAM OXALATE 294 70 18 15
LITHIUM CARBONATE 261 36 19 18
PAROXETINE HCL 241 54 20 25
BENZTROPINE MESYLATE 239 29 R 21 4
AMPHETAMINE SALT COMBO 198 29 S2 22 45
GABAPENTIN 188 69 23 31
DIVALPROEX SODIUM 187 63 24 20
CLOZAPINE 184 12 25 28
ZIPRASIDONE HCL 140 48 26 24
OXCARBAZEPINE 138 42 27 30
BUSPIRONE HCL 134 54 28 26
TOPIRAMATE 134 0 28 36
BUPROPION XL 131 55 30 19
HALOPERIDOL 129 17 31 23
OMEPRAZOLE 106 76 32 35
CHLORPROMAZINE HCL 105 16 33 74
PRISTIQ ER 103 30 34 36
ZYPREXA 97 26 35 63
LEXAPRO 91 27 36 51
AMITRIPTYLINE HCL 86 18 R 37 38
EXELON 86 67 37 46
ALPRAZOLAM 80 41 39 44
CARBAMAZEPINE 80 0 39 43
HYDROXYZINE PAMOATE 78 0 R 41 29
SEROQUEL XR 74 0 42 22
GEODON 74 17 42 66
SIMVASTATIN 71 50 44 50
IMIPRAMINE HCL 71 15 R 44 81
CLONAZEPAM 70 41 46 39
LEVOTHYROXINE SODIUM 68 49 47 42
ROPINIROLE HCL 67 56 48 78
INVEGA 62 0 49 34
METHYLPHENIDATE HCL 60 29 50 72
VENLAFAXINE HCL 59 28 51 64
LUNESTA 56 18 52 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.